149 related articles for article (PubMed ID: 2962879)
21. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
Imperato A; Mulas A; Di Chiara G
Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
[TBL] [Abstract][Full Text] [Related]
22. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
[TBL] [Abstract][Full Text] [Related]
23. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
24. D2 Dopamine receptor subtype mediates the inhibitory effect of dopamine on TRH-induced prolactin release from the bullfrog pituitary.
Nakano M; Minagawa A; Hasunuma I; Okada R; Tonon MC; Vaudry H; Yamamoto K; Kikuyama S; Machida T; Kobayashi T
Gen Comp Endocrinol; 2010 Sep; 168(2):287-92. PubMed ID: 20553721
[TBL] [Abstract][Full Text] [Related]
25. Modulation of dopaminergic terminal excitability by D1 selective agents.
Diana M; Young SJ; Groves PM
Neuropharmacology; 1989 Jan; 28(1):99-101. PubMed ID: 2522599
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
27. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
Hyttel J
Neuropharmacology; 1984 Dec; 23(12A):1395-401. PubMed ID: 6152023
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393.
Smiałowski A
Brain Res; 1990 Sep; 528(1):148-50. PubMed ID: 2147120
[TBL] [Abstract][Full Text] [Related]
30. Adenosine and its analogue (-)-N6-R-phenyl-isopropyladenosine modulate anterior pituitary adenylate cyclase activity and prolactin secretion in the rat.
Schettini G; Landolfi E; Meucci O; Florio T; Grimaldi M; Ventra C; Marino A
J Mol Endocrinol; 1990 Aug; 5(1):69-76. PubMed ID: 2397024
[TBL] [Abstract][Full Text] [Related]
31. Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat.
Newman ME; Lerer B
Neuropharmacology; 1989 Aug; 28(8):787-90. PubMed ID: 2674765
[TBL] [Abstract][Full Text] [Related]
32. Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats.
Gilbert DB; Cooper SJ
Brain Res Bull; 1985 Oct; 15(4):385-9. PubMed ID: 2933127
[TBL] [Abstract][Full Text] [Related]
33. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
34. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
Bradshaw CM; Sheridan RD; Szabadi E
Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
[TBL] [Abstract][Full Text] [Related]
35. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
Apud JA; Masotto C; Ongini E; Racagni G
Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
[TBL] [Abstract][Full Text] [Related]
36. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
Carlson JH; Bergstrom DA; Weick BG; Walters JR
Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
38. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
Rubinstein M; Gershanik O; Stefano FJ
Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
[TBL] [Abstract][Full Text] [Related]
39. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
[TBL] [Abstract][Full Text] [Related]
40. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
